HOUSE DOCKET, NO. 2992 FILED ON: 1/16/2025
HOUSE . . . . . . . . . . . . . . . No. 193
The Commonwealth of Massachusetts
_________________
PRESENTED BY:
Marcus S. Vaughn
_________________
To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
Court assembled:
The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill:
An Act to improve warning labels on THC products.
_______________
PETITION OF:
NAME: DISTRICT/ADDRESS: DATE ADDED:
Marcus S. Vaughn 9th Norfolk 1/16/2025
John F. Keenan Norfolk and Plymouth 6/3/2025
1 of 1

HOUSE DOCKET, NO. 2992 FILED ON: 1/16/2025
HOUSE . . . . . . . . . . . . . . . No. 193
By Representative Vaughn of Wrentham, a petition (accompanied by bill, House, No. 193) of
Marcus S. Vaughn relative to warning labels on products containing cannabis. Cannabis Policy.
The Commonwealth of Massachusetts
_______________
In the One Hundred and Ninety-Fourth General Court
(2025-2026)
_______________
An Act to improve warning labels on THC products.
Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority
of the same, as follows:
1 SECTION 1. Subsection (a1/2) of section 4 of chapter 94G of the General Laws is hereby
2 amended by striking clause (xxvi) and inserting in place thereof the following:
3 (xxvi) requirements for the labeling of a package containing marijuana or marijuana
4 products that shall, at a minimum, include: (1) a symbol or easily recognizable mark issued by
5 the commission that indicates the package contains marijuana or a marijuana product; (2) a
6 symbol or other easily recognizable mark issued by the commission on the package indicating to
7 children that the product is harmful to children; (3) the name and contact information of the
8 marijuana cultivator or the marijuana product manufacturer who produced the marijuana or
9 marijuana product; (4) the results of sampling, testing and analysis conducted by a licensed
10 independent testing laboratory; (5) a seal certifying the marijuana meets such testing standards;
11 (6) a unique batch number identifying the production batch associated with manufacturing,
12 processing, and cultivating; (7) a list of ingredients and possible allergens; (8) in bold, the
13 amount of delta-nine-tetrahydrocannabinol (Δ9–THC) in the package and in each serving of a
1 of 2

14 marijuana product as expressed in absolute terms and as a percentage of volume; (9) the number
15 of servings in a package if there are multiple servings; (10) a use-by date, if applicable; and (11)
16 the following statement, including capitalization: ''This product has not been analyzed or
17 approved by the FDA. There is limited information on the side effects of using this product, and
18 there may be associated health risks. Marijuana use during pregnancy and breast-feeding may
19 pose potential harms. It is against the law to drive or operate machinery when under the
20 influence of this product. KEEP THIS PRODUCT AWAY FROM CHILDREN.''; and (12)
21 comprehensive prominent rotating health warnings, based on the best available research on what
22 constitutes effective warnings for transmitting knowledge and achieving behavior change from
23 tobacco and cannabis warning research, including pictorial warnings if supported. These
24 regulations shall be periodically updated based on emerging science on cannabis and on warning
25 communication best practices. These warnings must also include the increased risk of
26 cannabinoid hyperemesis syndrome, cannabis use disorder, mood disorders, psychosis described
27 as paranoia, hallucinations, delusions, schizophrenia , and suicidal thoughts with use of THC-
28 containing marijuana products, especially when initiated young, used frequently, and/or with use
29 of products containing more than 10% THC.
2 of 2

[DELETED: :D/A:DAEITDSA Dn9k1nNh6]
[DELETED: Sa(ptscmm0i1(2p3a]
[DELETED: 4m5o6t7a8t9p0i1c2c3t4r5c6c7a8c9o]